Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2019

Open Access 01-01-2019 | Nutrition | Clinical Guides in Oncology

SEOM clinical guidelines on nutrition in cancer patients (2018)

Authors: R. de las Peñas, M. Majem, J. Perez-Altozano, J. A. Virizuela, E. Cancer, P. Diz, O. Donnay, A. Hurtado, P. Jimenez-Fonseca, M. J. Ocon

Published in: Clinical and Translational Oncology | Issue 1/2019

Login to get access

Abstract

Nutritional deficiency is a common medical problem that affects 15–40% of cancer patients. It negatively impacts their quality of life and can compromise treatment completion. Oncological therapies, such as surgery, radiation therapy, and drug therapies are improving survival rates. However, all these treatments can play a role in the development of malnutrition and/or metabolic alterations in cancer patients, induced by the tumor or by its treatment. Nutritional assessment of cancer patients is necessary at the time of diagnosis and throughout treatment, so as to detect nutritional deficiencies. The Patient-Generated Subjective Global Assessment method is the most widely used tool that also evaluates nutritional requirements. In this guideline, we will review the indications of nutritional interventions as well as artificial nutrition in general and according to the type of treatment (radiotherapy, surgery, or systemic therapy), or palliative care. Likewise, pharmacological agents and pharmaconutrients will be reviewed in addition to the role of regular physical activity.
Literature
1.
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49–64.CrossRef
2.
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–96.CrossRef
3.
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.CrossRefPubMed
4.
Thompson KL, Elliott L, Fuchs-Tarlovsky V, Levin RM, Voss AC, Piemonte T. Oncology evidence-based nutrition practice guideline for adults. J Acad Nutr Diet. 2018;117:297–310.CrossRef
5.
6.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.CrossRefPubMed
7.
Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29:154–9.CrossRefPubMed
8.
Ryan AM, Power DG, Daly L, Cushen SJ, Ni Bhuachalla E, Prado CM. Cancer associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75(2):199–211.CrossRefPubMed
9.
10.
Tewari N, Awad S, Lobo DN. Regulation of food intake after surgery and the gut brain axis. Curr Opin Clin Nutr Metab Care. 2013;16(5):569–75.CrossRefPubMed
11.
12.
Escortell Sánchez R, Reig García-Galbis M. Nutrición enteral en el estado nutricional del cáncer; revisión sistemática. Nutr Hosp. 2015;32(4):1408–16.PubMed
13.
Segura A, Pardo J, Jara C, Zugazabeitia L, Carulla J, de Las Peñas R, et al. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr. 2005;24(5):801–14.CrossRefPubMed
14.
Planas M, Álvarez-Hernández J, León-Sanz M, Celaya-Pérez S, Araujo K, de Lorenzo AG, on behalf of the PREDyCES® researchers. Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study. Support Care Cancer. 2016;24:429–35.CrossRefPubMed
15.
Virizuela JA, Camblor-Alvarez M, Uengo-Perez LM, Grande E, Álvarez-Hernández J, Sendrós-Madroño MJ. Nutritional support and parenteral nutrition in cancer patients: an expert consensus report. Clin Trans Oncol. 2018;20(5):619–29.CrossRef
16.
García-of-Lorenzo, director. Diccionario LID. Metabolismo y Nutrición. 1a ed. Madrid: LID Editorial Empresas, SL; 2007.
17.
Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623.CrossRefPubMed
18.
Vidal-Casariego A, Calleja-Fernández A, Villar-Taibo R, Kyriakos G, Balleste-ros-Pomar MD. Efficacy of arginine-enriched enteral formulas in the reduction of surgical complications in head and neck cancer: a systematic review and meta-analysis. Clin Nutr. 2014;33(6):951–7.CrossRefPubMed
19.
Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, Davidson SE, et al. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers (Review). Cochrane Database Syst Rev. 2018;1:CD012529.PubMed
20.
Corry J, Poon W, McPhee N, Milner AD, Cruickshank D, Porceddu SV, et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo) radiation. J Med Imaging Radiat Oncol. 2008;52:503–10.CrossRefPubMed
21.
Gomes CA Jr., Andriolo RB, Bennett C, Lustosa SA, Matos D, Waisberg DR, et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev. 2015;3:CD008096.
22.
Nugent B, Lewis S, O’Sullivan JM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev 2013;1:CD007904.
23.
Bozzetti F, Arends J, Lundhom K, Micklewright A, Zurcher G, Muscaritoli M. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009;28:445–54.CrossRefPubMed
24.
Gavazzi C, Bhoori S, Lovullo S, Cozzi G, Mariani L. Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol. 2006;101:374–9.CrossRefPubMed
25.
Kalaiselvan R, Theis VS, Dibb M, Teubner A, Anderson ID, Shaffer JL, et al. Radiation enteritis leading to intestinal failure: 1994 patient-years of experience in a national referral centre. Eur J Clin Nutr. 2014;68:166–70.CrossRefPubMed
26.
Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, Goedhart A, Lundholm K, Nitenberg G, et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol. 2006;28:5–23.PubMed
27.
Pekmezi DW, Demark-Wahnefried W. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol. 2011;50:167–78.CrossRefPubMed
28.
Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer. 2009;17:83–90.CrossRefPubMed
29.
Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, et al. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res. 2013;19:5456–64.CrossRefPubMed
Metadata
Title
SEOM clinical guidelines on nutrition in cancer patients (2018)
Authors
R. de las Peñas
M. Majem
J. Perez-Altozano
J. A. Virizuela
E. Cancer
P. Diz
O. Donnay
A. Hurtado
P. Jimenez-Fonseca
M. J. Ocon
Publication date
01-01-2019
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 1/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-02009-3

Other articles of this Issue 1/2019

Clinical and Translational Oncology 1/2019 Go to the issue

Clinical Guides in Oncology

SEOM clinical guidelines to primary prevention of cancer (2018)

Acknowledgement to Reviewers

Thanks to reviewers 2018

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)

Clinical Guides in Oncology

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

Clinical Guides in Oncology

SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018)

Clinical Guides in Oncology

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits